BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25982576)

  • 1. Study of SH2D1A gene mutation in paediatric patients with B-cell lymphoma.
    Koochakzadeh L; Hosseinverdi S; Hedayat M; Farahani F; Tofighi A; Eghbali M; Bidoki AZ; Izadyar M; Rahiminejad MS; Ramyar A; Aghamohammadi A; Rezaei N
    Allergol Immunopathol (Madr); 2015; 43(6):568-70. PubMed ID: 25982576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
    Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
    Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.
    Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T
    Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
    Woon ST; Ameratunga R; Croxson M; Taylor G; Neas K; Edkins E; Browett P; Gane E; Munn S
    Scand J Immunol; 2008 Aug; 68(2):153-8. PubMed ID: 18702745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.
    Rezaei N; Mahmoudi E; Aghamohammadi A; Das R; Nichols KE
    Br J Haematol; 2011 Jan; 152(1):13-30. PubMed ID: 21083659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
    Schuster V; Kreth HW
    Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
    Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel Mutations in SH2D1A Gene in X-linked Lymphoproliferative Syndrome, Diagnosed After B-Cell Non-Hodgkin Lymphoma.
    Sharapova SO; Fedorova AS; Pashchenko OE; Vahliarskaya SS; Guryanova IE; Migas AA; Kondratenko IV; Aleinikova OV
    J Pediatr Hematol Oncol; 2017 May; 39(4):e203-e206. PubMed ID: 28267077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
    Jin YY; Zhou W; Tian ZQ; Chen TX
    Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma.
    Parolini O; Kagerbauer B; Simonitsch-Klupp I; Ambros P; Jaeger U; Mann G; Haas OA; Morra M; Gadner H; Terhorst C; Knapp W; Holter W
    Ann Hematol; 2002 Aug; 81(8):441-7. PubMed ID: 12224001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
    Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
    J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
    Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
    Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
    Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
    Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.
    Sperl D; Benesch M; Urban C; Lackner H; Sovinz P; Speicher MR; Uhrig S; Schwarzbraun T; Schwinger W; zur Stadt U; Beutel K; Janka G; Scarpatetti M; Seidel MG
    Klin Padiatr; 2012 Oct; 224(6):386-9. PubMed ID: 23143765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.
    Tangye SG
    J Clin Immunol; 2014 Oct; 34(7):772-9. PubMed ID: 25085526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
    Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
    Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.
    Sylla BS; Murphy K; Cahir-McFarland E; Lane WS; Mosialos G; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7470-5. PubMed ID: 10852966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.